Recently, Arizona became the first of what may be a growing number of states to allow pharmaceutical companies to promote off-label use of their drugs. Here are some issues Medical Affairs departments should consider
Physicians are increasingly counting on CME and Thought Leaders to make decisions. Here are the strategies for Medical Affairs to engage with them at the local level
The first thing that most people worried about after Maria was not drug supplies. However, Puerto Rico is a major drug manufacturing center and the impacts are being felt
The best decisions will be based on your ability to balance the opinions of others with your own metrics. You often hear about mechanisms and trends from an adboard or agencies, but how do you verify those insights?
A deep dive into the PD-1/PD-L1 Inhibitor class as indicated for Melanoma, looking specifically at the Share of Scientific Voice and Scientific Expert analysis